Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of p53 molecular status in high-risk primary breast cancer.
Marchetti P, Cannita K, Ricevuto E, De Galitiis F, Di Rocco ZC, Tessitore A, Bisegna R, Porzio G, De Rubeis GP, Ventura T, Martinotti S, Ficorella C. Marchetti P, et al. Among authors: cannita k. Ann Oncol. 2003 May;14(5):704-8. doi: 10.1093/annonc/mdg197. Ann Oncol. 2003. PMID: 12702523 Free article.
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?].
Ricevuto E, Marchetti P, Cannita K, De Galitiis F, Di Rocco ZC, Tessitore A, Martella F, Bisegna R, Porzio G, Bafile A, Vicentini R, Resta V, Mattucci S, Ventura T, Martinotti S, de Rubeis GP, Ficorella C. Ricevuto E, et al. Among authors: cannita k. Tumori. 2003 Jul-Aug;89(4 Suppl):197-9. Tumori. 2003. PMID: 12903592 Review. Italian.
Novel P53 mutations detected by FAMA in colorectal cancers.
De Galitiis F, Cannita K, Tessitore A, Martella F, Di Rocco ZC, Russo A, Adamo V, Iacobelli S, Martinotti S, Marchetti P, Ficorella C, Ricevuto E; Consorzio Interuniversitario Nazionale Bio-Oncologia. De Galitiis F, et al. Among authors: cannita k. Ann Oncol. 2006 Jun;17 Suppl 7:vii78-83. doi: 10.1093/annonc/mdl957. Ann Oncol. 2006. PMID: 16760300 Free article.
The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?
Bruera G, Cannita K, Tessitore A, Russo A, Alesse E, Ficorella C, Ricevuto E. Bruera G, et al. Among authors: cannita k. Crit Rev Oncol Hematol. 2015 Mar;93(3):190-202. doi: 10.1016/j.critrevonc.2014.10.004. Epub 2014 Oct 16. Crit Rev Oncol Hematol. 2015. PMID: 25459669 Review.
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
Cocciolone V, Cannita K, Calandrella ML, Ricevuto E, Baldi PL, Sidoni T, Irelli A, Paradisi S, Pizzorno L, Resta V, Bafile A, Alesse E, Tessitore A, Ficorella C. Cocciolone V, et al. Among authors: cannita k. Oncotarget. 2017 Jun 16;8(42):72031-72043. doi: 10.18632/oncotarget.18526. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069766 Free PMC article.
104 results